Warning: The NCBI web site requires JavaScript to function. more...
Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML).
Galili N, Devemy E, Raza A.
J Hematol Oncol. 2008 Jul 10;1:8.
Related citations
Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, Saberwal G, Eklund EA.
J Biol Chem. 2009 Jan 23;284(4):2549-67. Epub 2008 Nov 19.
PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.
Ikezoe T, Chen S, Saito T, Asou H, Kyo T, Tanosaki S, Heber D, Taguchi H, Koeffler HP.
Int J Oncol. 2003 Oct;23(4):1203-11.
Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR.
Liang R, Huang GS, Wang Z, Chen XQ, Bai QX, Zhang YQ, Dong BX, Wang WQ.
Int J Hematol. 2008 Mar;87(2):152-66. Epub 2008 Feb 21.
SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells.
Liang H, Samanta S, Nagarajan L.
Oncogene. 2005 Apr 14;24(16):2625-34.
Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemia.
Bae J, Martinson JA, Klingemann HG.
Cell Immunol. 2004 Jan;227(1):38-50.
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ, Cheng YC, Liu CR, Lin S, Liu HE.
Exp Hematol. 2006 Nov;34(11):1480-9.
Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Hu ZB, Ma W, Zaborski M, MacLeod R, Quentmeier H, Drexler HG.
Leukemia. 1996 Jun;10(6):1025-40.
Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
Hassan HT, Zander A.
Acta Haematol. 1996;95(3-4):257-62. Review.
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.
Greiner J, Li L, Ringhoffer M, Barth TF, Giannopoulos K, Guillaume P, Ritter G, Wiesneth M, Döhner H, Schmitt M.
Blood. 2005 Aug 1;106(3):938-45. Epub 2005 Apr 12.
Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
Gibbs JD, Liebermann DA, Hoffman B.
Oncogene. 2008 Jan 3;27(1):98-106. Epub 2007 Jun 25.
Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia.
Liu W, Guo M, Xu YB, Li D, Zhou ZN, Wu YL, Chen Z, Kogan SC, Chen GQ.
Blood. 2006 Jan 15;107(2):698-707. Epub 2005 Sep 15.
Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C, Hassan HT.
Leuk Res. 2006 Mar;30(3):296-302. Epub 2005 Aug 19.
Leukemia-targeting ligands isolated from phage-display peptide libraries.
Jäger S, Jahnke A, Wilmes T, Adebahr S, Vögtle FN, Delima-Hahn E, Pfeifer D, Berg T, Lübbert M, Trepel M.
Leukemia. 2007 Mar;21(3):411-20. Epub 2007 Jan 25.
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A.
Folia Med Cracov. 2001;42(3):5-80. Review. Polish.
Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
Rangatia J, Vangala RK, Singh SM, Peer Zada AA, Elsässer A, Kohlmann A, Haferlach T, Tenen DG, Hiddemann W, Behre G.
Oncogene. 2003 Jul 24;22(30):4760-4.
MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells.
Yin L, Wu Z, Avigan D, Rosenblatt J, Stone R, Kharbanda S, Kufe D.
Blood. 2011 May 5;117(18):4863-70. Epub 2011 Mar 21.
Gefitinib induces myeloid differentiation of acute myeloid leukemia.
Stegmaier K, Corsello SM, Ross KN, Wong JS, Deangelo DJ, Golub TR.
Blood. 2005 Oct 15;106(8):2841-8. Epub 2005 Jul 5.
The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.
Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, Robert-Lezenes J, Chomienne C, Smadja-Joffe F.
Leuk Lymphoma. 2004 Aug;45(8):1501-10. Review.
Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J, Pabst T, Koeffler HP, Niklaus G, Loetscher P, Fey MF, Tobler A.
Leukemia. 1997 Jan;11(1):54-63.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on